You are here: Industry Insights > coronavirus

News List

Ultrapotent COVID-19 vaccine candidate designed via computer worldpharmanews
November 04, 2020
An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels ten-times greater than is seen in people who have recovered from COVID-19 infections.
Japan’s cabinet approves plan for free COVID-19 vaccines expresspharma
October 29, 2020
Japan’s cabinet approved a plan on Tuesday to use public funds to provide novel coronavirus vaccines to the public for free.
Peru refuses Covid-19 vaccine purchase deal with AstraZeneca pharmaceutical-technology
October 26, 2020
The Peruvian government has refused to sign an agreement with AstraZeneca to purchase coronavirus vaccine as the latter failed to provide sufficient data from its studies.
First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people expresspharma
October 22, 2020
Preliminary results from the late-stage human trial of Russia’s main coronavirus vaccine candidate could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday.
Popular COVID-19 conspiracies linked to vaccine 'hesitancy' worldpharmanews
October 16, 2020
A new study of beliefs and attitudes toward COVID-19 in five different countries - UK, US, Ireland, Mexico and Spain - has identified how much traction some prominent conspiracy theories have within these populations.
How One Hospital Kept COVID Transmissions at Nearly Zero drugs.com
September 24, 2020
Infection control measures implemented in response to the coronavirus pandemic kept transmission of the virus to patients within a Boston hospital at nearly zero, according to a new study.
UK’s chief medical officers upgrade coronavirus alert level pharmatimes
September 23, 2020
The chief medical officers for England, Scotland, Wales and Northern Ireland have recommended all four nations to upgrade their coronavirus alert levels from three to four following a rise in cases.
Researchers uncover early results about an existing tuberculosis vaccine that has been hypothesized to help against the coronavirus worldpharmanews
September 22, 2020
While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their ...
Access to coronavirus tests should be ‘top priority’, says NHS Confederation director pharmatimes
September 21, 2020
Following the latest NHS Test and Trace figures, NHS Confederation director Layla McCay said that access to testing should be a ‘top priority’ for the government ahead of a potential second wave in the UK.
Nine COVID-19 vaccine makers sign safety pledge expresspharma
September 17, 2020
The companies said in a statement they would uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page